 | • レポートコード：MRC2312MG04823 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の心臓ヘルスソリューション市場規模と予測を収録しています。・世界の心臓ヘルスソリューション市場：売上、2018年-2023年、2024年-2029年 ・世界の心臓ヘルスソリューション市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の心臓ヘルスソリューション市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「心血管画像検査」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 心臓ヘルスソリューションのグローバル主要企業は、CARDIO HEALTH SOLUTIONS、 Biotrial、 Banook Group、 Bioclinica、 Certara L.P.、 Celerion, Inc、 ERT, Inc、 Laboratory Corporation of America Holdings、 Medpace Holdings, Inc.、 Ncardia AG、 Richmond Pharmacology、 PhysioStim、 IQVIA、 BioTelemetry, Inc、 Pharmaceutical Product Development, LLC、 Shanghai Medicilon Inc、 SGS SA、 Spaulding Clinical Research, LLCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、心臓ヘルスソリューションのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の心臓ヘルスソリューション市場：タイプ別、2018年-2023年、2024年-2029年 世界の心臓ヘルスソリューション市場：タイプ別市場シェア、2022年 ・心血管画像検査、血圧測定、心電図測定、その他 世界の心臓ヘルスソリューション市場：用途別、2018年-2023年、2024年-2029年 世界の心臓ヘルスソリューション市場：用途別市場シェア、2022年 ・バイオ医薬品企業、研究受託機関（CRO）、その他 世界の心臓ヘルスソリューション市場：地域・国別、2018年-2023年、2024年-2029年 世界の心臓ヘルスソリューション市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における心臓ヘルスソリューションのグローバル売上、2018年-2023年 ・主要企業における心臓ヘルスソリューションのグローバル売上シェア、2022年 ・主要企業における心臓ヘルスソリューションのグローバル販売量、2018年-2023年 ・主要企業における心臓ヘルスソリューションのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CARDIO HEALTH SOLUTIONS、 Biotrial、 Banook Group、 Bioclinica、 Certara L.P.、 Celerion, Inc、 ERT, Inc、 Laboratory Corporation of America Holdings、 Medpace Holdings, Inc.、 Ncardia AG、 Richmond Pharmacology、 PhysioStim、 IQVIA、 BioTelemetry, Inc、 Pharmaceutical Product Development, LLC、 Shanghai Medicilon Inc、 SGS SA、 Spaulding Clinical Research, LLC ************************************************************* ・調査・分析レポートの概要 心臓ヘルスソリューション市場の定義 市場セグメント 世界の心臓ヘルスソリューション市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の心臓ヘルスソリューション市場規模 世界の心臓ヘルスソリューション市場規模：2022年 VS 2029年 世界の心臓ヘルスソリューション市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの心臓ヘルスソリューションの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の心臓ヘルスソリューション製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：心血管画像検査、血圧測定、心電図測定、その他 心臓ヘルスソリューションのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：バイオ医薬品企業、研究受託機関（CRO）、その他 心臓ヘルスソリューションの用途別グローバル売上・予測 ・地域別市場分析 地域別心臓ヘルスソリューション市場規模 2022年と2029年 地域別心臓ヘルスソリューション売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CARDIO HEALTH SOLUTIONS、 Biotrial、 Banook Group、 Bioclinica、 Certara L.P.、 Celerion, Inc、 ERT, Inc、 Laboratory Corporation of America Holdings、 Medpace Holdings, Inc.、 Ncardia AG、 Richmond Pharmacology、 PhysioStim、 IQVIA、 BioTelemetry, Inc、 Pharmaceutical Product Development, LLC、 Shanghai Medicilon Inc、 SGS SA、 Spaulding Clinical Research, LLC ... |
This research report provides a comprehensive analysis of the Cardiac Health Solutions market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cardiac Health Solutions market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cardiac Health Solutions, challenges faced by the industry, and potential opportunities for market players.
The global Cardiac Health Solutions market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cardiac Health Solutions market presents opportunities for various stakeholders, including Biopharmaceuticals Companies, Contract Research Organization(CRO). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cardiac Health Solutions market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cardiac Health Solutions market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Cardiac Health Solutions market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cardiac Health Solutions market.
Market Overview: The report provides a comprehensive overview of the Cardiac Health Solutions market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cardiovascular Imaging, Blood Pressure Measurement), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cardiac Health Solutions market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cardiac Health Solutions market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cardiac Health Solutions market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cardiac Health Solutions market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cardiac Health Solutions market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cardiac Health Solutions market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cardiac Health Solutions, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cardiac Health Solutions market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cardiac Health Solutions market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cardiovascular Imaging
Blood Pressure Measurement
Ecg Measurement
Others
Market segment by Application
Biopharmaceuticals Companies
Contract Research Organization(CRO)
Others
Global Cardiac Health Solutions Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CARDIO HEALTH SOLUTIONS
Biotrial
Banook Group
Bioclinica
Certara L.P.
Celerion, Inc
ERT, Inc
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Ncardia AG
Richmond Pharmacology
PhysioStim
IQVIA
BioTelemetry, Inc
Pharmaceutical Product Development, LLC
Shanghai Medicilon Inc
SGS SA
Spaulding Clinical Research, LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Health Solutions, market overview.
Chapter 2: Global Cardiac Health Solutions market size in revenue.
Chapter 3: Detailed analysis of Cardiac Health Solutions company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Health Solutions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Cardiac Health Solutions Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiac Health Solutions Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiac Health Solutions Overall Market Size
2.1 Global Cardiac Health Solutions Market Size: 2022 VS 2029
2.2 Global Cardiac Health Solutions Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Health Solutions Players in Global Market
3.2 Top Global Cardiac Health Solutions Companies Ranked by Revenue
3.3 Global Cardiac Health Solutions Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Health Solutions Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cardiac Health Solutions Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Health Solutions Players in Global Market
3.6.1 List of Global Tier 1 Cardiac Health Solutions Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiac Health Solutions Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cardiac Health Solutions Market Size Markets, 2022 & 2029
4.1.2 Cardiovascular Imaging
4.1.3 Blood Pressure Measurement
4.1.4 Ecg Measurement
4.1.5 Others
4.2 By Type – Global Cardiac Health Solutions Revenue & Forecasts
4.2.1 By Type – Global Cardiac Health Solutions Revenue, 2018-2023
4.2.2 By Type – Global Cardiac Health Solutions Revenue, 2024-2029
4.2.3 By Type – Global Cardiac Health Solutions Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cardiac Health Solutions Market Size, 2022 & 2029
5.1.2 Biopharmaceuticals Companies
5.1.3 Contract Research Organization(CRO)
5.1.4 Others
5.2 By Application – Global Cardiac Health Solutions Revenue & Forecasts
5.2.1 By Application – Global Cardiac Health Solutions Revenue, 2018-2023
5.2.2 By Application – Global Cardiac Health Solutions Revenue, 2024-2029
5.2.3 By Application – Global Cardiac Health Solutions Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cardiac Health Solutions Market Size, 2022 & 2029
6.2 By Region – Global Cardiac Health Solutions Revenue & Forecasts
6.2.1 By Region – Global Cardiac Health Solutions Revenue, 2018-2023
6.2.2 By Region – Global Cardiac Health Solutions Revenue, 2024-2029
6.2.3 By Region – Global Cardiac Health Solutions Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cardiac Health Solutions Revenue, 2018-2029
6.3.2 US Cardiac Health Solutions Market Size, 2018-2029
6.3.3 Canada Cardiac Health Solutions Market Size, 2018-2029
6.3.4 Mexico Cardiac Health Solutions Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cardiac Health Solutions Revenue, 2018-2029
6.4.2 Germany Cardiac Health Solutions Market Size, 2018-2029
6.4.3 France Cardiac Health Solutions Market Size, 2018-2029
6.4.4 U.K. Cardiac Health Solutions Market Size, 2018-2029
6.4.5 Italy Cardiac Health Solutions Market Size, 2018-2029
6.4.6 Russia Cardiac Health Solutions Market Size, 2018-2029
6.4.7 Nordic Countries Cardiac Health Solutions Market Size, 2018-2029
6.4.8 Benelux Cardiac Health Solutions Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cardiac Health Solutions Revenue, 2018-2029
6.5.2 China Cardiac Health Solutions Market Size, 2018-2029
6.5.3 Japan Cardiac Health Solutions Market Size, 2018-2029
6.5.4 South Korea Cardiac Health Solutions Market Size, 2018-2029
6.5.5 Southeast Asia Cardiac Health Solutions Market Size, 2018-2029
6.5.6 India Cardiac Health Solutions Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cardiac Health Solutions Revenue, 2018-2029
6.6.2 Brazil Cardiac Health Solutions Market Size, 2018-2029
6.6.3 Argentina Cardiac Health Solutions Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cardiac Health Solutions Revenue, 2018-2029
6.7.2 Turkey Cardiac Health Solutions Market Size, 2018-2029
6.7.3 Israel Cardiac Health Solutions Market Size, 2018-2029
6.7.4 Saudi Arabia Cardiac Health Solutions Market Size, 2018-2029
6.7.5 UAE Cardiac Health Solutions Market Size, 2018-2029
7 Cardiac Health Solutions Companies Profiles
7.1 CARDIO HEALTH SOLUTIONS
7.1.1 CARDIO HEALTH SOLUTIONS Company Summary
7.1.2 CARDIO HEALTH SOLUTIONS Business Overview
7.1.3 CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Major Product Offerings
7.1.4 CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.1.5 CARDIO HEALTH SOLUTIONS Key News & Latest Developments
7.2 Biotrial
7.2.1 Biotrial Company Summary
7.2.2 Biotrial Business Overview
7.2.3 Biotrial Cardiac Health Solutions Major Product Offerings
7.2.4 Biotrial Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.2.5 Biotrial Key News & Latest Developments
7.3 Banook Group
7.3.1 Banook Group Company Summary
7.3.2 Banook Group Business Overview
7.3.3 Banook Group Cardiac Health Solutions Major Product Offerings
7.3.4 Banook Group Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.3.5 Banook Group Key News & Latest Developments
7.4 Bioclinica
7.4.1 Bioclinica Company Summary
7.4.2 Bioclinica Business Overview
7.4.3 Bioclinica Cardiac Health Solutions Major Product Offerings
7.4.4 Bioclinica Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.4.5 Bioclinica Key News & Latest Developments
7.5 Certara L.P.
7.5.1 Certara L.P. Company Summary
7.5.2 Certara L.P. Business Overview
7.5.3 Certara L.P. Cardiac Health Solutions Major Product Offerings
7.5.4 Certara L.P. Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.5.5 Certara L.P. Key News & Latest Developments
7.6 Celerion, Inc
7.6.1 Celerion, Inc Company Summary
7.6.2 Celerion, Inc Business Overview
7.6.3 Celerion, Inc Cardiac Health Solutions Major Product Offerings
7.6.4 Celerion, Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.6.5 Celerion, Inc Key News & Latest Developments
7.7 ERT, Inc
7.7.1 ERT, Inc Company Summary
7.7.2 ERT, Inc Business Overview
7.7.3 ERT, Inc Cardiac Health Solutions Major Product Offerings
7.7.4 ERT, Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.7.5 ERT, Inc Key News & Latest Developments
7.8 Laboratory Corporation of America Holdings
7.8.1 Laboratory Corporation of America Holdings Company Summary
7.8.2 Laboratory Corporation of America Holdings Business Overview
7.8.3 Laboratory Corporation of America Holdings Cardiac Health Solutions Major Product Offerings
7.8.4 Laboratory Corporation of America Holdings Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.8.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.9 Medpace Holdings, Inc.
7.9.1 Medpace Holdings, Inc. Company Summary
7.9.2 Medpace Holdings, Inc. Business Overview
7.9.3 Medpace Holdings, Inc. Cardiac Health Solutions Major Product Offerings
7.9.4 Medpace Holdings, Inc. Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.9.5 Medpace Holdings, Inc. Key News & Latest Developments
7.10 Ncardia AG
7.10.1 Ncardia AG Company Summary
7.10.2 Ncardia AG Business Overview
7.10.3 Ncardia AG Cardiac Health Solutions Major Product Offerings
7.10.4 Ncardia AG Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.10.5 Ncardia AG Key News & Latest Developments
7.11 Richmond Pharmacology
7.11.1 Richmond Pharmacology Company Summary
7.11.2 Richmond Pharmacology Business Overview
7.11.3 Richmond Pharmacology Cardiac Health Solutions Major Product Offerings
7.11.4 Richmond Pharmacology Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.11.5 Richmond Pharmacology Key News & Latest Developments
7.12 PhysioStim
7.12.1 PhysioStim Company Summary
7.12.2 PhysioStim Business Overview
7.12.3 PhysioStim Cardiac Health Solutions Major Product Offerings
7.12.4 PhysioStim Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.12.5 PhysioStim Key News & Latest Developments
7.13 IQVIA
7.13.1 IQVIA Company Summary
7.13.2 IQVIA Business Overview
7.13.3 IQVIA Cardiac Health Solutions Major Product Offerings
7.13.4 IQVIA Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.13.5 IQVIA Key News & Latest Developments
7.14 BioTelemetry, Inc
7.14.1 BioTelemetry, Inc Company Summary
7.14.2 BioTelemetry, Inc Business Overview
7.14.3 BioTelemetry, Inc Cardiac Health Solutions Major Product Offerings
7.14.4 BioTelemetry, Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.14.5 BioTelemetry, Inc Key News & Latest Developments
7.15 Pharmaceutical Product Development, LLC
7.15.1 Pharmaceutical Product Development, LLC Company Summary
7.15.2 Pharmaceutical Product Development, LLC Business Overview
7.15.3 Pharmaceutical Product Development, LLC Cardiac Health Solutions Major Product Offerings
7.15.4 Pharmaceutical Product Development, LLC Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.15.5 Pharmaceutical Product Development, LLC Key News & Latest Developments
7.16 Shanghai Medicilon Inc
7.16.1 Shanghai Medicilon Inc Company Summary
7.16.2 Shanghai Medicilon Inc Business Overview
7.16.3 Shanghai Medicilon Inc Cardiac Health Solutions Major Product Offerings
7.16.4 Shanghai Medicilon Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.16.5 Shanghai Medicilon Inc Key News & Latest Developments
7.17 SGS SA
7.17.1 SGS SA Company Summary
7.17.2 SGS SA Business Overview
7.17.3 SGS SA Cardiac Health Solutions Major Product Offerings
7.17.4 SGS SA Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.17.5 SGS SA Key News & Latest Developments
7.18 Spaulding Clinical Research, LLC
7.18.1 Spaulding Clinical Research, LLC Company Summary
7.18.2 Spaulding Clinical Research, LLC Business Overview
7.18.3 Spaulding Clinical Research, LLC Cardiac Health Solutions Major Product Offerings
7.18.4 Spaulding Clinical Research, LLC Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.18.5 Spaulding Clinical Research, LLC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
